Raffles PharmaTech provides innovative pharmaceutical companies with safe and efficient R&D and manufacturing services, based on good science and technological platforms, such as enzyme catalysis and continuous flow micro-reactors.
The continuous flow platform has demonstrated advantages for a number of transformations, including hydrogenation, diazotization and nitration processes.
       Recently, we developed a process for a key intermediate using our continuous flow platform, achieving full conversion in 15 seconds residence time, and purity of 99.8%.